Consensus Enlivex Deutsche Boerse AG

Stocks

1BT

IL0011319527

Market Closed - Deutsche Boerse AG Other stock markets 09:48:41 2026-07-17 EDT			5-day change	1st Jan Change
3.700 ^EUR	-25.70%		-41.73%	-60.22%

07-13	Enlivex Receives FDA Regenerative Medicine Advanced Therapy Designation for Allocetra in Age-Related Knee Osteoarthritis	CI
06-15	Enlivex Therapeutics Granted Patent in Australia for Allocetra to Treat Osteoarthritis	MT

Evolution of the Average Target: Enlivex

Evolution of the Target Price: Enlivex

Changes in Analyst Recommendations: Enlivex

0aea1e98868d89dd.758nHFaSpfnXh-ImGu5Ea1nXsOzaskjWpKLiA8o_4GY.iswfTyDXkrynvtRsY7kFPxG0ho2-03qy99qbR5tZzQ7X8Gh3AePUppPrgQ~50f86bc34e0d27ffa57eae9b455c431f

Analysts' recommendations: Enlivex

24-06-11	HC Wainwright Adjusts Price Target on Enlivex Therapeutics to $6 From $7, Maintains Buy Rating	MT
24-04-12	HC Wainwright Adjusts Enlivex Therapeutics Price Target to $7 From $12, Maintains Buy Rating	MT
23-09-25	HC Wainwright Cuts Enlivex Therapeutics Price Target to $12 From $15, Maintains Buy Rating	MT
22-05-02	HC Wainwright Adjusts Enlivex Therapeutics' Price Target to $15 from $33, Keeps Buy Rating	MT

More recommendations

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

4.680USD

Average target price

300.00USD

Spread / Average Target

+6,310.25%

High Price Target

300.00USD

Spread / Highest target

+6,310.25%

Low Price Target

300.00USD

Spread / Lowest Target

+6,310.25%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

HC Wainwright

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

4.680USD

Average target price

300.00USD

Spread / Average Target

+6,310.25%

Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar

The best tools reserved for subscribers to boost the performance of your investments!